Skip to main content

Advertisement

SpringerLink
Log in

Critical care management of patients with hemophagocytic lymphohistiocytosis

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening condition associated with multiple organ dysfunction. We sought to describe ICU management and outcomes in HLH patients meeting HLH-2004 criteria and to identify determinants of mortality.

Design

Retrospective study between January 1998 and January 2009.

Setting

Medical ICU of a teaching hospital.

Patients

Among the 72 patients fulfilling the HLH-2004 criteria, we report the 56 patients with complete follow-up and no missing data.

Interventions

None.

Measurements and main results

Clinical and laboratory data were abstracted from the medical records. Median SOFA score at admission was 6.5 (IQR, 4–8). At ICU admission, the number of HLH-2004 criteria was 6 (5–7). Sixty-six precipitating factors were found in 52 patients and consisted of 43 tumoral causes (8 Castleman’s diseases, 18 B cell lymphoma and 17 various malignancies), 13 non-viral infections and 10 viral infections. Underlying immune deficiency was present in 38 (67.8%) patients. Etoposide was used in 45 patients, corticosteroids in 31 and intravenous immunoglobulins in 3. Mechanical ventilation was required in 32 patients, vasoactive agents in 30 and renal replacement therapy in 19. Hospital mortality was 29/56 patients. By multivariate analysis, factors associated with increased hospital death were shock at ICU admission [OR, 4.33; 95% confidence interval (95% CI), 1.11–16.90; P = 0.03] and platelet count <30 g/l (OR, 4.75; 95% CI, 1.20–18.81; P = 0.02). B cell lymphoma [odds ratio (OR), 0.17; 95% CI, 0.04–0.80; P = 0.02] and Castleman’s disease (OR, 0.11; 95% CI, 0.02–0.90; P = 0.04) were associated with increased hospital survival.

Conclusions

Aggressive supportive care combined with specific treatment of the precipitating factor can produce meaningful survival in patients with HLH responsible for multiple organ failures. Survival is highest in patients with HLH related to Castleman’s disease or B cell lymphoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Wilson RF (1981) Etiology, diagnosis, and prognosis of positive blood cultures. Am Surg 47:112–115

    CAS  PubMed  Google Scholar 

  2. Gauvin F, Toledano B, Champagne J, Lacroix J (2000) Reactive hemophagocytic syndrome presenting as a component of multiple organ dysfunction syndrome. Crit Care Med 28:3341–3345

    Article  CAS  PubMed  Google Scholar 

  3. Janka GE (2005) Hemophagocytic lymphohistiocytosis. Hematology 10(Suppl 1):104–107

    Article  PubMed  Google Scholar 

  4. Henter JI, Elinder G, Ost A (1991) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 18:29–33

    CAS  PubMed  Google Scholar 

  5. Janka GE (2007) Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr 166:95–109

    Article  PubMed  Google Scholar 

  6. Castillo L, Carcillo J (2009) Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med 10:387–392

    Article  PubMed  Google Scholar 

  7. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124–131

    Article  PubMed  Google Scholar 

  8. Creput C, Galicier L, Buyse S, Azoulay E (2008) Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med 34:1177–1187

    Article  CAS  PubMed  Google Scholar 

  9. Risdall RJ, Brunning RD, Hernandez JI, Gordon DH (1984) Bacteria-associated hemophagocytic syndrome. Cancer 54:2968–2972

    Article  CAS  PubMed  Google Scholar 

  10. Grom AA (2003) Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol 15:587–590

    Article  PubMed  Google Scholar 

  11. Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM (2001) Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 40:1285–1292

    Article  CAS  Google Scholar 

  12. Strauss R, Neureiter D, Westenburger B, Wehler M, Kirchner T, Hahn EG (2004) Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients–a postmortem clinicopathologic analysis. Crit Care Med 32:1316–1321

    Article  PubMed  Google Scholar 

  13. Stephan F, Thioliere B, Verdy E, Tulliez M (1997) Role of hemophagocytic histiocytosis in the etiology of thrombocytopenia in patients with sepsis syndrome or septic shock. Clin Infect Dis 25:1159–1164

    Article  CAS  PubMed  Google Scholar 

  14. Kaito K, Kobayashi M, Katayama T, Otsubo H, Ogasawara Y, Sekita T, Saeki A, Sakamoto M, Nishiwaki K, Masuoka H, Shimada T, Yoshida M, Hosoya T (1997) Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol 59:247–253

    Article  CAS  PubMed  Google Scholar 

  15. Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, Dupond JL, Larroche C, Piette AM, Mechenstock D, Ziza JM, Arlaud J, Labussiere AS, Desvaux A, Baty V, Blanche P, Schaeffer A, Piette JC, Guillevin L, Boissonnas A, Christoforov B (2003) Reactive hemophagocytic syndrome in adult systemic disease: report of 26 cases and literature review. Arthritis Rheum 49:633–639

    Article  PubMed  Google Scholar 

  16. Imashuku S (2000) Advances in the management of hemophagocytic lymphohistiocytosis. Int J Hematol 72:1–11

    CAS  PubMed  Google Scholar 

  17. Peigne V, Rusinova K, Karlin L, Darmon M, Fermand JP, Schlemmer B, Azoulay E (2009) Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 35:512–518

    Article  PubMed  Google Scholar 

  18. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710

    Article  CAS  PubMed  Google Scholar 

  19. Francois B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H (1997) Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 103:114–120

    Article  CAS  PubMed  Google Scholar 

  20. Yang K, Azoulay E, Attalah L, Zahar JR, Van de Louw A, Cerf C, Soussy CJ, Duvaldestin P, Brochard L, Brun-Buisson C, Harf A, Delclaux C (2003) Bactericidal activity response of blood neutrophils from critically ill patients to in vitro granulocyte colony-stimulating factor stimulation. Intensive Care Med 29:396–402

    PubMed  Google Scholar 

  21. Delclaux C, Azoulay E (2003) Inflammatory response to infectious pulmonary injury. Eur Respir J Suppl 42:10s–14s

    Article  CAS  PubMed  Google Scholar 

  22. Azoulay E, Delclaux C (2004) Is there a place for granulocyte colony-stimulating factor in non-neutropenic critically ill patients? Intensive Care Med 30:10–17

    Article  PubMed  Google Scholar 

  23. Le Tulzo Y, Pangault C, Amiot L, Guilloux V, Tribut O, Arvieux C, Camus C, Fauchet R, Thomas R, Drenou B (2004) Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. Am J Respir Crit Care Med 169:1144–1151

    Article  PubMed  Google Scholar 

  24. Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, Hamoudi R, Daniel MT, Agbalika F, Boshoff C, Clauvel JP, Isaacson PG, Meignin V (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99:2331–2336

    Article  CAS  PubMed  Google Scholar 

  25. Scott D, Cabral L, Harrington WJ Jr (2001) Treatment of HIV-associated multicentric Castleman’s disease with oral etoposide. Am J Hematol 66:148–150

    Article  CAS  PubMed  Google Scholar 

  26. Fardet L, Coppo P, Kettaneh A, Dehoux M, Cabane J, Lambotte O (2008) Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome. Arthritis Rheum 58:1521–1527

    Article  CAS  PubMed  Google Scholar 

  27. Jones AE, Trzeciak S, Kline JA (2009) The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 37:1649–1654

    Article  PubMed  Google Scholar 

  28. Azoulay E, Recher C, Alberti C, Soufir L, Leleu G, Le Gall JR, Fermand JP, Schlemmer B (1999) Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 25:1395–1401

    Article  CAS  PubMed  Google Scholar 

  29. Imashuku S, Hibi S, Ohara T, Iwai A, Sako M, Kato M, Arakawa H, Sotomatsu M, Kataoka S, Asami K, Hasegawa D, Kosaka Y, Sano K, Igarashi N, Maruhashi K, Ichimi R, Kawasaki H, Maeda N, Tanizawa A, Arai K, Abe T, Hisakawa H, Miyashita H, Henter JI (1999) Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society. Blood 93:1869–1874

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Dr A. Wolfe for assistance with the manuscript.

Author information

Authors and Affiliations

  1. Medical Intensive Care Unit, Clinical Immunology, Pathology and Dermatalogy departments, Saint-Louis Teaching Hospital, University Paris-7 Paris-Diderot, UFR de Médecine, AP-HP, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France

    Sophie Buyse, Luis Teixeira, Lionel Galicier, Eric Mariotte, Virginie Lemiale, Amélie Seguin, Philippe Bertheau, Emmanuel Canet, Adrienne de Labarthe, Michaël Darmon, Michel Rybojad, Benoit Schlemmer & Elie Azoulay

Authors
  1. Sophie Buyse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luis Teixeira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lionel Galicier
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eric Mariotte
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Virginie Lemiale
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Amélie Seguin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Philippe Bertheau
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Emmanuel Canet
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Adrienne de Labarthe
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Michaël Darmon
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Michel Rybojad
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Benoit Schlemmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Elie Azoulay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elie Azoulay.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 34 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buyse, S., Teixeira, L., Galicier, L. et al. Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med 36, 1695–1702 (2010). https://doi.org/10.1007/s00134-010-1936-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-010-1936-z

Keywords

Search

Navigation